Perspectives for Managed Care Organizations on the Burden of Multiple Sclerosis and the Cost-Benefits of Disease-Modifying Therapies

Disease-modifying therapies (DMTs) are a core component of multiple sclerosis (MS) management. Given current constraints on health care expenditures, the relative cost-effectiveness of these therapies needs to be considered when making treatment decisions. The objective of this article is to review...

Descripción completa

Detalles Bibliográficos
Autores principales: Owens, Gary M., Olvey, Eleanor L., Skrepnek, Grant H., Pill, Michael W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2013
Materias:
Cea
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438212/
https://www.ncbi.nlm.nih.gov/pubmed/23383732
http://dx.doi.org/10.18553/jmcp.2013.19.s1.S41

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438212/
https://www.ncbi.nlm.nih.gov/pubmed/23383732
http://dx.doi.org/10.18553/jmcp.2013.19.s1.S41

Ejemplares similares